Dr. Miguel Antonio Rodriguez Guerra, MD

Dr. Rodriguez Guerra practices at Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network.

Dr. Rodriguez Guerra's NPI, 1568942183, was assigned on August 14, 2018. Dr. Rodriguez Guerra holds West Virginia license 33859.

Dr. Rodriguez Guerra's primary practice is Cabell Huntington Hospital, at 1340 Hal Greer Boulevard, Huntington, WV 25701 in Cabell County. The practice phone is (304) 526-2000.

Dr. Rodriguez Guerra's primary practice is Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network. The medical group on file is Marshall Health. Dmand AI also links Dr. Rodriguez Guerra to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rodriguez Guerra practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Rodriguez Guerra's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Rodriguez Guerra is licensed in West Virginia.

CMS data shows 367 Medicare services from Dr. Rodriguez Guerra across 4 procedure codes in 2024, for 126 Medicare patients. Medicare paid $40,398 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Rodriguez Guerra in 2024. The largest group is 75 to 84, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rodriguez Guerra's median patient age at 63, with 46% women.

In 2024, Dr. Rodriguez Guerra wrote 139 Medicare Part D claims for 57 patients. 86% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $122 in total drug cost. In 2023, CMS named 100 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rodriguez Guerra for performance year 2024, reported as part of a group.

CMS Open Payments shows 15 general payments to Dr. Rodriguez Guerra from 6 drug and device companies in 2025. Food and beverage make up the largest share, 80% of the total. Abbott Laboratories paid the most, $255.